Bifidobacterium adolescentis for Healthy Aging
(VITAL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Are You a Good Fit for This Trial?
This trial is for midlife adults who are interested in healthy aging. Participants should be generally healthy without any major medical conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Bifidobacterium adolescentis (iVS-1) or placebo once daily for 150 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Bifidobacterium adolescentis (iVS-1)
Trial Overview
The trial is testing if a probiotic called Bifidobacterium adolescentis iVS-1 can improve markers of biological aging, metabolic health, and functional outcomes compared to a placebo. It's randomized and double-blind, meaning neither participants nor researchers know who gets the real probiotic or placebo.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Probiotic Capsule
Placebo capsule
Find a Clinic Near You
Who Is Running the Clinical Trial?
Synbiotic Health
Lead Sponsor
MusB Research
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.